Telomir Pharmaceuticals, Inc. (TELO) AI Dilution Summary

Cash was $5,170,286 at 2026-06-30 against estimated monthly burn of $337,444. The company funds itself through an active ATM with Rodman & Renshaw LLC. That ATM is authorised to $100,000,000, with 3,222,575 shares sold since the program began through 2026-06-30, and sales after 2026-06-30 are not yet reported. Most recently, it raised $5,600,000 gross in a private placement of 4,843,300 shares at $1.16 that closed 2026-10-05.